Jorn Aldag - 01 Feb 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role: Chief Executive Officer, Director
Signature: /s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol: HOOK
Transactions as of: 01 Feb 2022
Net transactions value: +$263,031
Form type: 4
Filing time: 01 Feb 2022, 19:44:52 UTC
Next filing: 20 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HOOK	Common Stock	Award	$143,472	+47,824	+1159%	$3.00	51,952	01 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HOOK	Stock Option (Right to Buy)	Award	$119,559	+39,853		$3.00	39,853	01 Feb 2022	Common Stock	39,853	$1.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was awarded 47,824 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
F2	This stock option is fully vested.